Vitrolife AB (publ) (OM:VITR) signed an agreement to acquire Stb Zorg B.V. for ?18 million on May 2, 2024. The initial purchase price, on a net debt free basis is ?9.6 million which will be paid at closing. In addition, there is an earn-out component, structured over a 3-year period, based on scale up and achievement of sales growth milestones to a maximum payout of ?8.4 million.

eFertility will be reported under the Technologies business area. The expected closing is mid-May 2024 and will be financed through the Vitrolife Group´s cash.